Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Kestra Medical Technologies Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
KIRKLAND, Wash., June 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical: Skipping A Heartbeat
Kestra Medical Technologies, Ltd. shows strong sales growth but faces significant operating losses and a concerning slowdown in sequential revenue growth. Despite a large addressable market and innovative cardiac device, the company's one-product focus and high valuation amplify risks. Recent quarters reveal only modest revenue increases, casting doubt on the sustainability of Kestra's growth trajectory post-IPO.
Kestra Medical Technologies Announces Appointment of Conor Hanley to its Board of Directors
KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future KIRKLAND, Wash., May 13, 2025 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) announced the finalists for the Entrepreneur Of The Year 2025 Mountain West Award.
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
KIRKLAND, Wash., April 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to participate in the following upcoming investor conferences:
Kestra Showcases Real-World Outcomes for ASSURE WCD at Heart Rhythm 2025
KIRKLAND, Wash., April 29, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025
KIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra's initial public offering exercised in full their previously disclosed over-allotment option and have purchased 1,782,352 shares of common stock at a public offering price of $17.00 per share. After giving effect to the sale of over-allotment option, the total number of shares sold by Kestra in the initial public offering was 13,664,704 and the total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $232 million. The issuance and sale of the over-allotment option closed today.
Kestra Medical Technologies: A Potential Promising Public Offering
Kestra Medical Technologies has seen rapid growth but incurs substantial operating losses, making its valuation exercise a hard one. The company's Cardiac Recovery System, including the ASSURE WCD, addresses a significant market need for sudden cardiac arrest intervention. Despite strong product adoption and a large addressable market, risks include high losses, being a one-product business, and potential growth slowdown.
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $202 million. All of the common shares were offered by Kestra. Kestra's common shares began trading on the Nasdaq Global Select Market on March 6, 2025, under the ticker symbol "KMTS".
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering
KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the pricing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share.
